Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts DOI Creative Commons

Xuehui Deng,

Bingfeng Lin, Wenlong Xiao

и другие.

Drug Design Development and Therapy, Год журнала: 2025, Номер Volume 19, С. 1595 - 1608

Опубликована: Март 1, 2025

Specnuezhenide (SPN) is an iridoid glycoside isolated from Fructus Ligustri Lucidi, herb prescribed for the treatment of senile osteoporosis. However, direct role SPN on bone metabolism remains unclear. In this study, effects d-galactose (d-gal)-induced mice, marrow mesenchymal stem cells (BMSCs), and nuclear factor-κB ligand-induced osteoclasts were examined. Micro-computed tomography was used to observe microstructure. Osteogenesis examined using Western blotting alkaline phosphatase staining. Osteoclastogenesis F-actin ring Senescence-associated β-galactosidase detect cell senescence. addition, expression Takeda G protein-coupled receptor 5 (TGR5)/farnesoid X (FXR) signaling pathway-related genes proteins determined through quantitative real-time polymerase chain reaction immunofluorescence. Oral administration improved microstructure in d-gal-induced mice increased mineral density, volume, trabecular thickness, number. also upregulated osteogenesis markers osteocalcin, morphogenetic protein 2, runt-related transcription factor 2 downregulated osteoclasis tartrate-resistant acid phosphatase, factor-κB, activated T-cells bone. Furthermore, staining, inhibited formation, reduced activity senescence-associated vitro. Mechanistically, TGR5/FXR pathway BMSCs osteoclasts. The protective abolished after addition TGR5 inhibitor SBI-115 or FXR DY268. Moreover, could elevate mRNA levels TGR5, FXR, downstream small heterodimer partner alleviated osteoporosis senescence by activating pathway.

Язык: Английский

An Engineered Cellular Carrier Delivers miR-138-5p to Enhance Mitophagy and Protect Hypoxic-Injured Neurons via the DNMT3A/Rhebl1 Axis DOI Creative Commons

Xingjia Zhu,

Qianqian Liu,

Fengwei Zhu

и другие.

Acta Biomaterialia, Год журнала: 2024, Номер 186, С. 424 - 438

Опубликована: Авг. 8, 2024

Mitophagy influences the progression and prognosis of ischemic stroke (IS). However, whether DNA methylation in brain is associated with altered mitophagy hypoxia-injured neurons remains unclear. Here, miR-138–5p was found to be highly expressed exosomes secreted by astrocytes stimulated oxygen glucose deprivation/re-oxygenation (OGD/R), which could influence recovery OGD/R-injured through autophagy. Mechanistically, promotes stable expression Ras homolog enriched like 1(Rhebl1) DNA-methyltransferase-3a (DNMT3A), thereby enhancing ubiquitin-dependent maintain mitochondrial homeostasis. Furthermore, we employed glycosylation engineering bioorthogonal click reactions load mirna onto surface microglia deliver them injured region utilising inflammatory chemotactic properties achieve drug-targeted delivery central nervous system (CNS). Our findings demonstrate improves function miR-138–5p/DNMT3A/Rhebl1 axis. Additionally, our engineered cell vector-targeted promising for treating IS. In this study, demonstrated that under hypoxia plays a critical role treatment neurons. And find new target miR-138–5p, DNMT3A, affects neuronal thus exerts protective effect regulating Rbebl1. have developed carrier combining membrane utilized via intravenous injection. This groundbreaking study not only provides novel therapeutic approach ischemia-reperfusion but also establishes solid theoretical foundation further research on targeted drug diseases clinical applications.

Язык: Английский

Процитировано

4

Fraxin inhibits ovariectomized-induced bone loss and osteoclastogenesis by suppressing ROS activity DOI
Han Zhou,

Pianpian Chen,

Chengyi Zhao

и другие.

International Immunopharmacology, Год журнала: 2025, Номер 147, С. 113871 - 113871

Опубликована: Янв. 10, 2025

Язык: Английский

Процитировано

0

Therapeutic targets in aging-related osteoarthritis: A focus on the extracellular matrix homeostasis DOI Creative Commons
Hao Wan, Ming‐Fu Chang, Di Shi

и другие.

Life Sciences, Год журнала: 2025, Номер unknown, С. 123487 - 123487

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Oral Administration of Alpha-Ketoglutarate Partially Ameliorates Cadmium-Compromised BMSC Mobilization and Cranial Bone Repair DOI

Yuna Ji,

Pengchao Zheng, Xinchen Wang

и другие.

Food Bioscience, Год журнала: 2025, Номер unknown, С. 106169 - 106169

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts DOI Creative Commons

Xuehui Deng,

Bingfeng Lin, Wenlong Xiao

и другие.

Drug Design Development and Therapy, Год журнала: 2025, Номер Volume 19, С. 1595 - 1608

Опубликована: Март 1, 2025

Specnuezhenide (SPN) is an iridoid glycoside isolated from Fructus Ligustri Lucidi, herb prescribed for the treatment of senile osteoporosis. However, direct role SPN on bone metabolism remains unclear. In this study, effects d-galactose (d-gal)-induced mice, marrow mesenchymal stem cells (BMSCs), and nuclear factor-κB ligand-induced osteoclasts were examined. Micro-computed tomography was used to observe microstructure. Osteogenesis examined using Western blotting alkaline phosphatase staining. Osteoclastogenesis F-actin ring Senescence-associated β-galactosidase detect cell senescence. addition, expression Takeda G protein-coupled receptor 5 (TGR5)/farnesoid X (FXR) signaling pathway-related genes proteins determined through quantitative real-time polymerase chain reaction immunofluorescence. Oral administration improved microstructure in d-gal-induced mice increased mineral density, volume, trabecular thickness, number. also upregulated osteogenesis markers osteocalcin, morphogenetic protein 2, runt-related transcription factor 2 downregulated osteoclasis tartrate-resistant acid phosphatase, factor-κB, activated T-cells bone. Furthermore, staining, inhibited formation, reduced activity senescence-associated vitro. Mechanistically, TGR5/FXR pathway BMSCs osteoclasts. The protective abolished after addition TGR5 inhibitor SBI-115 or FXR DY268. Moreover, could elevate mRNA levels TGR5, FXR, downstream small heterodimer partner alleviated osteoporosis senescence by activating pathway.

Язык: Английский

Процитировано

0